Skip to content

A study to test how well different doses of BI 3034701 are tolerated by healthy men and people with overweight or obesity

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-508767-79-00
Acronym
1507-0001
Enrollment
125
Registered
2024-04-22
Start date
2024-05-15
Completion date
2025-10-07
Last updated
2025-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer trial

Interventions

None listed

Sponsors

Boehringer Ingelheim International GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026